Mid
Q
QGENAI Stock Diagnostic Report
Qiagen reaffirms 2026 EPS of at least $2.43 while guiding Q3 EPS of at least $0.62
Qiagen reaffirmed its 2026 EPS target and raised its Q3 guidance, increasing confidence in its performance outlook.
View Source Article ↗
AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
QGEN Analysis History (Last 30 Days)